Interventional cardiology in a whole new light

Open menu

News & Events

OPSENS – Q3 2019 – RECORD QUARTERLY FFR REVENUES OF $5.2 M, UP 49%

11 July 2019

Quebec City, Quebec, July 11, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter of 2019. Highlights Consolidated revenues of $7.9 M for the third quarter of 2019 compared with $6.4 M for the third quarter of 2018, an increase of $1.5 M or 23%; Fractional…

Read more

Visit Opsens at CVI 2019

2 July 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at CVI 2019 (Cardiovascular Innovations 2019) by attending Opsens’ complimentary lunch  and educational symposium. Register Now! The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with…

Read more